Using a hollow microstructured transdermal system to deliver vaccine directly to the dermis.
Dave Cunningham
Advertisement
Dave Cunningham is director, corporate development at Goodwin Biotechnology.
Articles by Dave Cunningham
Advertisement
Latest Updated Articles
Optimizing a Unique Cancer Vaccine for Intradermal DeliveryPublished: September 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Everything to Know About Cell and Gene Therapy in 2025
2
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
3
CGT Innovations: The Three-Pronged Strategy for Industry Growth (Part 2)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
